Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/65747
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Domenech, Mirian | - |
dc.contributor.author | Damián, Diana | - |
dc.contributor.author | Ardanuy Tisaire, María Carmen | - |
dc.contributor.author | Liñares Louzao, Josefina | - |
dc.contributor.author | Fenoll, Asunción | - |
dc.contributor.author | García, Ernesto | - |
dc.date.accessioned | 2015-06-08T06:08:48Z | - |
dc.date.available | 2015-06-08T06:08:48Z | - |
dc.date.issued | 2015-04-30 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | http://hdl.handle.net/2445/65747 | - |
dc.description.abstract | Background: Since the use of pneumococcal conjugate vaccines PCV7 and PCV13 in children became widespread, invasive pneumococcal disease (IPD) has dramatically decreased. Nevertheless, there has been a rise in incidence of Streptococcus pneumoniae non-vaccine serotypes (NVT) colonising the human nasopharynx. Nasopharyngeal colonisation, an essential step in the development of S. pneumoniae-induced IPD, is associated with biofilm formation. Although the capsule is the main pneumococcal virulence factor, the formation of pneumococcal biofilms might, in fact, be limited by the presence of capsular polysaccharide (CPS). Methodology/Principal Findings: We used clinical isolates of 16 emerging, non-PCV13 serotypes as well as isogenic transformants of the same serotypes. The biofilm formation capacity of isogenic transformants expressing CPSs from NVT was evaluated in vitro to ascertain whether this trait can be used to predict the emergence of NVT. Fourteen out of 16 NVT analysed were not good biofilm formers, presumably because of the presence of CPS. In contrast, serotypes 11A and 35B formed >45% of the biofilm produced by the non-encapsulated M11 strain. Conclusions/Significance This study suggest that emerging, NVT serotypes 11A and 35B deserve a close surveillance. | - |
dc.format.extent | 11 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Public Library of Science (PLoS) | - |
dc.relation.isformatof | Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0125636 | - |
dc.relation.ispartof | PLoS One, 2015, vol. 10, num. 4, p. 1-11 | - |
dc.relation.uri | http://dx.doi.org/10.1371/journal.pone.0125636 | - |
dc.rights | cc-by (c) Domenech, Mirian et al., 2015 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Patologia i Terapèutica Experimental) | - |
dc.subject.classification | Pneumococs | - |
dc.subject.classification | Vacuna antipneumocòccica | - |
dc.subject.classification | Infants | - |
dc.subject.other | Streptococcus pneumonia | - |
dc.subject.other | Pneumococcal vaccine | - |
dc.subject.other | Children | - |
dc.title | Emerging, non-PCV13 serotypes 11A and 35B of Streptococcus pneumoniae show high potential for biofilm formation in vitro | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 652353 | - |
dc.date.updated | 2015-06-08T06:08:48Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 25927917 | - |
Appears in Collections: | Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
652353.pdf | 791.52 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License